25 results on '"tolbutamide"'
Search Results
2. Licorice Botanical Dietary Supplements - Metabolism and Safety in Women
3. Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
4. Phenotyping of High Dose Rifampicin (PHENORIF)
5. Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
6. A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
7. Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein
8. Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects
9. Effects of Genotype on CYP2C9 Drug Interactions
10. Drug Interaction Study of CT1812 in Healthy Volunteers
11. Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
12. A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma (JZAR)
13. A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers
14. Incretin-based Drugs and Acute Pancreatitis
15. Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients
16. Incretin-based Drugs and the Risk of Heart Failure
17. Incretin-based Drugs and Pancreatic Cancer
18. A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates
19. A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
20. Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors
21. Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
22. Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers
23. To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
24. AZD2066 Cocktail Study
25. Blockade of Vascular Potassium Channels During Human Endotoxemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.